MedPath

Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.

Conditions
Covid-19
Interventions
Other: observational
Registration Number
NCT04363099
Lead Sponsor
Maison de Sante Pluridisciplinaire de Creil
Brief Summary

Since December 2019, a new agent, the coronavirus SARS-Cov-2, has spread from China to the rest of the world causing an international epidemic of respiratory diseases called COVID-19. Oise was one of the first clusters in France, with more than 4,000 confirmed cases. A significant proportion (80%) of patients with COVID-19 are ambulatory. However, few data are available for this particular population in France. Thus, few clear recommendations are available.

We propose to conduct a large cohort of observation of suspected or confirmed COVID-19 patients on an ambulatory basis in the Oise region. This observatory will make it possible to describe the epidemiological characteristics and initial management of COVID-19 patients and to identify early severity factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • patients with covid 19 symptoms
  • patients who had a contact with a person PCR Covid 19+
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
outpatients COVID 19 positiveobservational-
Primary Outcome Measures
NameTimeMethod
clinical description of covid 19 ambulatory cases.3 months
Secondary Outcome Measures
NameTimeMethod
Biological and radiological description of ambulatory cases3 months
Prevalence of positive cases (PCR and/or serological positive)3 months

Trial Locations

Locations (1)

Msp de Creil

🇫🇷

Creil, France

© Copyright 2025. All Rights Reserved by MedPath